Nuvation Bio, Inc.(NUVB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NUVB Nuvation Bio, Inc.

Trading 11-06 15:08:04 EST

4.18

-0.01

-0.24%

High4.33	Low3.98	Vol2.57M
Open4.22	D1 Closing4.19	Amplitude8.33%
Mkt Cap1.48B	Tradable Cap1.11B	Total Shares354.02M
T/O10.67M	T/O Rate0.97%	Tradable Shares266.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NUVB","market":"US","secType":"STK","nameCN":"Nuvation Bio, Inc.","latestPrice":4.1801,"timestamp":1793995677968,"preClose":4.19,"halted":0,"volume":2574932,"delay":0,"changeRate":-0.002362768496420052,"floatShares":266000000,"shares":354017638,"eps":-0.390507,"marketStatus":"Trading","change":-0.0099,"latestTime":"11-06 15:08:04 EST","open":4.22,"high":4.329,"low":3.98,"amount":10665982.722775199,"amplitude":0.083294,"askPrice":4.19,"askSize":1412,"bidPrice":4.18,"bidSize":1977,"shortable":0,"etf":0,"ttmEps":-0.390507,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1793998800000},"marketStatusCode":2,"adr":0,"exchange":"NYSE","adjPreClose":4.19,"preHourTrading":{"tag":"盘前","latestPrice":4.3487,"preClose":4.19,"latestTime":"09:27 EST","volume":15503,"amount":66802.76806599999,"timestamp":1793975224752,"change":0.1587,"changeRate":0.037876,"amplitude":0.045346},"postHourTrading":{"tag":"盘后","latestPrice":4.12,"preClose":4.19,"latestTime":"19:49 EST","volume":347938,"amount":1458249.5195,"timestamp":1793926179146,"change":-0.07,"changeRate":-0.016706,"amplitude":0.121718},"volumeRatio":0.481391,"impliedVol":1.7425,"impliedVolPercentile":0.8526},"requestUrl":"/m/hq/s/NUVB","defaultTab":"news","newsList":[{"id":"2681851769","title":"Nuvation Bio Stock In Focus After Earnings And Phase 3 Trial Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2681851769","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681851769?lang=en_us&edition=fundamental","pubTime":"2026-11-06 17:33","pubTimestamp":1793957622,"startTime":"0","endTime":"0","summary":"SSasha JovanovicNovember 6, 2026","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/nuvation-bio-stock-in-focus-after-earnings-and-phase-3-trial","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/nuvation-bio-stock-in-focus-after-earnings-and-phase-3-trial","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681071249","title":"B. Riley Adjusts Nuvation Bio Price Target to $13 From $14, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2681071249","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681071249?lang=en_us&edition=fundamental","pubTime":"2026-11-05 22:17","pubTimestamp":1793888269,"startTime":"0","endTime":"0","summary":"Nuvation Bio (NUVB) has an average rating of buy and mean price target of $13.10, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681583071","title":"Nuvation Bio price target lowered to $13 from $14 at B. Riley","url":"https://stock-news.laohu8.com/highlight/detail?id=2681583071","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681583071?lang=en_us&edition=fundamental","pubTime":"2026-11-05 22:16","pubTimestamp":1793888174,"startTime":"0","endTime":"0","summary":"B. Riley lowered the firm’s price target on Nuvation Bio (NUVB) to $13 from $14 and keeps a Buy rating on the shares. Nuvation Bio’s Q3 total reven...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvation-bio-price-target-lowered-to-13-from-14-at-b-riley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvation-bio-price-target-lowered-to-13-from-14-at-b-riley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681015537","title":"Analysts Offer Insights on Healthcare Companies: MannKind (MNKD) and Nuvation Bio (NUVB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2681015537","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681015537?lang=en_us&edition=fundamental","pubTime":"2026-11-05 10:30","pubTimestamp":1793845812,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on MannKind (MNKD) and Nuvation Bio (NUVB) with bullish...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mannkind-mnkd-and-nuvation-bio-nuvb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mannkind-mnkd-and-nuvation-bio-nuvb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","XBI","BK4585","HCSG","BK4588","LABU","XLV","BK4139","BK4584","LU0029874061.USD","BK4007","BK4581","MNKD","BK4137","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681091978","title":"Nuvation Bio Presents Ibtrozi Launch Update, Reports $27.5 Million in Q3 U.S. Net Product Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2681091978","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681091978?lang=en_us&edition=fundamental","pubTime":"2026-11-05 07:03","pubTimestamp":1793833434,"startTime":"0","endTime":"0","summary":"Nuvation Bio Presents IBTROZI Launch Update, Reports $27.5 Million in Q3 U.S. Net Product RevenueNuvation Bio expects its approximately $663 million cash balance to fund a path to profitability withou","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nNDL4LklZC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681410099","title":"Nuvation Bio Inc. Reports Results for the Quarter Ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2681410099","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681410099?lang=en_us&edition=fundamental","pubTime":"2026-11-05 06:40","pubTimestamp":1793832037,"startTime":"0","endTime":"0","summary":"Nuvation Bio Inc. reports results for the quarter ended September 30 - Earnings SummaryNuvation Bio Inc.NUVB.Nreported a quarterly adjusted loss of 12 cents per share for the quarter ended September 3","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nL5N46L3JQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681953240","title":"Nuvation Bio Q3 Revenue up on Ibtrozi Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2681953240","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681953240?lang=en_us&edition=fundamental","pubTime":"2026-11-05 05:46","pubTimestamp":1793828807,"startTime":"0","endTime":"0","summary":"Nuvation Bio Q3 revenue up onIBTROZI salesOverviewOncology drugmaker's Q3 revenue rose to $45 mln, up from a year earlierNet loss for Q3 narrowed to $41.9 mln from $55.8 mln last yearFDA granted Fast ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nL2N46L1DJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCRX","LU2456880835.USD","LU1035775433.USD","TBXU","BK4585","BK4588","IE0002141913.USD","LU1585245621.USD","BK4567","LU2362540622.SGD","LU0256863811.USD","IE00B19Z3581.USD","BBH","LU1674673691.USD","IE0009355771.USD","LU0109394709.USD","GNMX","LU0289739699.SGD","LU1674673428.USD","LU0058720904.USD","IE00B2B36J28.USD","LU0234570918.USD","LU1430594728.SGD","LU2065171311.SGD","NBIX","LU1093756325.SGD","IDNA","LU2362541513.USD","NUVB","LU0154245673.USD","LU2462157665.USD","LU2065170008.USD","IBB","LU0154245756.USD","LU1093756168.USD","PBE","IE00BZ9MQY76.HKD","VRTX","LU2324357040.USD","IBBQ","IE00BJJMRZ35.SGD","LU0823416689.USD","LU0889565916.HKD","SG9999001176.SGD","IE00B4R5TH58.HKD","LU0061475181.USD","LU2417539215.USD","LU0079474960.USD","BIB","BK4547"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681060427","title":"Nuvation Bio Q3 Net Loss Narrows 25% Year over Year to $41.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2681060427","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681060427?lang=en_us&edition=fundamental","pubTime":"2026-11-05 05:15","pubTimestamp":1793826901,"startTime":"0","endTime":"0","summary":"Nuvation Bio Q3 net loss narrows 25% year over year to $41.9 millionNuvation Bio’s third-quarter 2026 net loss narrowed 25% year over year to $41.9 million.Total revenue more than tripled year over ye","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nNDL8yZkJw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681067960","title":"Nuvation Bio Q3 EPS $(0.12), Inline, Sales $44.951M Beat $34.224M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2681067960","media":"Benzinga Earnings","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681067960?lang=en_us&edition=fundamental","pubTime":"2026-11-05 05:07","pubTimestamp":1793826453,"startTime":"0","endTime":"0","summary":"Nuvation Bio (NYSE:NUVB) reported quarterly losses of $(0.12) per share which met the analyst consensus estimate. This is a 25 percent increase over losses of $(0.16) per share from the same period last year.  The","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/11/62888319/nuvation-bio-q3-eps-0-12-inline-sales-44-951m-beat-34-224m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681067164","title":"Nuvation Bio Q3 EPS USD -0.12","url":"https://stock-news.laohu8.com/highlight/detail?id=2681067164","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681067164?lang=en_us&edition=fundamental","pubTime":"2026-11-05 05:06","pubTimestamp":1793826362,"startTime":"0","endTime":"0","summary":"BRIEF-Nuvation Bio Q3 EPS USD -0.12Nov 04 (Reuters) - Nuvation Bio Q3 income from pperations USD -42.21 million.Q3 net income USD -41.899 millionQ3 pretax profit USD -41.899 million","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nPLX447LSD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680705551","title":"Our Pick Of The Best Penny Stocks In November 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2680705551","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680705551?lang=en_us&edition=fundamental","pubTime":"2026-11-04 05:28","pubTimestamp":1793741332,"startTime":"0","endTime":"0","summary":"Stock markets just got a fresh reminder of how fragile sentiment can be after a sharp pullback in AI shares and the US 10 year Treasury yield moving toward 5%. Big, debt fueled stories can suddenly look exposed when funding costs stay elevated. That is why financially solid, low priced companies can look interesting right now. This article breaks down three such under the radar penny stocks from our quality focused screener.\nThe three stocks highlighted here offer a compelling starting point...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/our-pick-of-the-best-penny-stocks-in-november-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/our-pick-of-the-best-penny-stocks-in-november-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2362541273.HKD","LU0979878070.USD","SGXZ58947870.SGD","NUVB","LU1839390173.USD","BK4124",".IXIC","LU2362541513.USD","00800","LU0210637038.USD","LU0532188223.SGD","LU1242518931.SGD","LU2362540622.SGD","SG9999002406.SGD","SG9999002679.SGD","LU1242518857.USD","SG9999001135.SGD","SG9999002620.SGD","LU2045819591.USD","SG9999006266.SGD","BK4007","BK4122","BK4609","GRAB","WRD","SG9999013460.SGD","LU2125910500.SGD","SG9999013478.USD","LU0441851309.USD","GRAG","SG9999002604.SGD","SG9999013486.USD","BK4230","BK4022","SG9999002414.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680875747","title":"Nuvation Bio to Present Updated Phase 2 Safusidenib Results in Glioma at SNO Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2680875747","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680875747?lang=en_us&edition=fundamental","pubTime":"2026-11-02 21:05","pubTimestamp":1793624707,"startTime":"0","endTime":"0","summary":"Nuvation Bio to Present Updated Phase 2 Safusidenib Results in Glioma at SNO MeetingNuvation Bio will present updated Phase 2 safusidenib results Nov. 13, 2026, at the Society for Neuro-Oncology annua","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261102:nNDL3Y2b4R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679244377","title":"3 Penny Stocks With Revenue Growth Up To 71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679244377","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679244377?lang=en_us&edition=fundamental","pubTime":"2026-10-31 01:32","pubTimestamp":1793381569,"startTime":"0","endTime":"0","summary":"Crypto investors just watched Binance report a record $6.3b hack, a reminder that chasing the next big thing can come with brutal downside. Cash strapped traders are asking where to find growth potential without taking casino level risks. That is where financially healthier, low priced shares become interesting. This article highlights three under the radar, sub US$5 stocks that combine smaller size with stronger balance sheet discipline.\nThe three stocks highlighted here offer a compelling...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/3-penny-stocks-with-revenue-growth-up-to-71","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/3-penny-stocks-with-revenue-growth-up-to-71","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999001135.SGD","BK4122","LU2125910500.SGD","SG9999002620.SGD","LU1839390173.USD","BK4137","NUVB","SG9999002604.SGD","GRAB",".IXIC","SG9999002406.SGD","LU0441851309.USD","BK4022","LU0210637038.USD","BK4007","SGXZ58947870.SGD","SG9999006266.SGD","LU2362541513.USD","SG9999002414.USD","GRAG","SG9999002679.SGD","SG9999013478.USD","BK4230","SG9999013460.SGD","AUR","LU2362541273.HKD","BK4023","LU0532188223.SGD","LU2045819591.USD","LU1242518931.SGD","SG9999013486.USD","LU1242518857.USD","LU2362540622.SGD","LU0979878070.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679401235","title":"Nuvation Bio Expands Phase 3 Safusidenib Glioma Trial to Six European Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2679401235","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679401235?lang=en_us&edition=fundamental","pubTime":"2026-10-29 20:05","pubTimestamp":1793275532,"startTime":"0","endTime":"0","summary":"Nuvation Bio Expands Phase 3 Safusidenib Glioma Trial to Six European CountriesNuvation Bio will expand its pivotal Phase 3 SIGMA trial of investigational safusidenib for IDH1-mutant glioma to six Eur","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nNDL1hRCkg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679537401","title":"Nuvation Bio to Expand Pivotal Phase 3 Sigma Study of Safusidenib for Idh1-Mutant Glioma to Six European Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2679537401","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679537401?lang=en_us&edition=fundamental","pubTime":"2026-10-29 20:00","pubTimestamp":1793275225,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nFWN46F1TS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115515404","title":"Earning Preview: Nuvation Bio, Inc. Q3 revenue expected to increase by 417.45%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1115515404","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115515404?lang=en_us&edition=fundamental","pubTime":"2026-10-29 00:40","pubTimestamp":1793205653,"startTime":"0","endTime":"0","summary":"Abstract Nuvation Bio, Inc. is scheduled to report quarterly results on November 4, 2026 Post-Mkt; this preview synthesizes consensus forecasts, last quarter’s performance, and current-quarter...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Earning Preview: Nuvation Bio, Inc. Q3 revenue expected to increase by 417.45%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677960752","title":"Nuvation Bio And 2 Penny Stocks To Own","url":"https://stock-news.laohu8.com/highlight/detail?id=2677960752","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677960752?lang=en_us&edition=fundamental","pubTime":"2026-10-23 00:38","pubTimestamp":1792687080,"startTime":"0","endTime":"0","summary":"Oil prices recently pushed above $111 a barrel after attacks on Saudi infrastructure and rising Iran risk, putting energy costs and inflation firmly back on the radar. Higher input prices can punish weak balance sheets and highly diluted plays. That is where a basket of sturdier, still cheap penny stocks with cleaner finances and strong growth forecasts becomes interesting. This article breaks down three of the strongest candidates from that group.\nThe stocks covered below are just a small...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/nuvation-bio-and-2-penny-stocks-to-own","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/nuvation-bio-and-2-penny-stocks-to-own","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","NUVB","GUER","BK4141","JVA","BK4212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677060467","title":"Nuvation Bio to Report Third Quarter 2026 Financial Results and Provide Business Update on November 4, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2677060467","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677060467?lang=en_us&edition=fundamental","pubTime":"2026-10-22 04:05","pubTimestamp":1792613102,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nTUA3PWB9Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677676826","title":"October 2026's Top Insider-Owned Growth Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2677676826","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677676826?lang=en_us&edition=fundamental","pubTime":"2026-10-21 19:05","pubTimestamp":1792580730,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has remained flat, yet it is up 12% over the past year with earnings forecast to grow by 17% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business in its future potential.","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/october-2026s-top-insider-owned-growth-stocks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/october-2026s-top-insider-owned-growth-stocks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4156","LU1559883803.SGD","STDN","PSCH","CORT","FBT","LU0566484027.USD","NUVB","BK4007","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675372786","title":"Our Pick Of The Best Penny Stocks In October 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2675372786","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675372786?lang=en_us&edition=fundamental","pubTime":"2026-10-15 10:34","pubTimestamp":1792031688,"startTime":"0","endTime":"0","summary":"When consumer prices rise faster than worker paychecks, every dollar has to work harder. That pressure often pushes investors to look beyond the crowded big-cap space and toward lower priced shares of financially sound smaller businesses that may offer more room for upside per dollar invested. This article zeroes in on three such lower priced stocks that pass strict balance sheet and cash discipline filters.\nThe three stocks highlighted here offer a compelling starting point if you want...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551730-choice2-card/1789070492827","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551730-choice2-card/1789070492827"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gdrx/goodrx-holdings/news/our-pick-of-the-best-penny-stocks-in-october-2026-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gdrx/goodrx-holdings/news/our-pick-of-the-best-penny-stocks-in-october-2026-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999013460.SGD","LU1839390173.USD","LU0441851309.USD","LU2045819591.USD","LU0979878070.USD","LU1242518931.SGD","BK4230","GDRX","SGXZ58947870.SGD","LU0532188223.SGD","LU2362540622.SGD","BK4167","SG9999002620.SGD","BK4022","BK4007","BK4122","LU2362541513.USD","NUVB","SG9999001135.SGD","LU0210637038.USD","SG9999013478.USD","SG9999002414.USD",".IXIC","SG9999002406.SGD","LU2362541273.HKD","SG9999002604.SGD","SG9999006266.SGD","SG9999002679.SGD","LU1242518857.USD","LU2125910500.SGD","GRAB","SG9999013486.USD","GRAG"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.1216},{"period":"1month","weight":-0.1414},{"period":"3month","weight":-0.3652},{"period":"6month","weight":-0.1253},{"period":"1year","weight":-0.1484},{"period":"ytd","weight":-0.5324}],"compareEarnings":[{"period":"1week","weight":-0.0473},{"period":"1month","weight":-0.0592},{"period":"3month","weight":-0.0521},{"period":"6month","weight":-0.0063},{"period":"1year","weight":0.0818},{"period":"ytd","weight":0.0749}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio's proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung , M.D., who previously founded Medivation, Inc., which brought to patients one of the world's leading prostate cancer medicines. Nuvation Bio has offices in New York and San Francisco .","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.099824},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.044723},{"month":3,"riseRate":0.5,"avgChangeRate":0.083814},{"month":4,"riseRate":0.5,"avgChangeRate":0.010626},{"month":5,"riseRate":0.666667,"avgChangeRate":0.014611},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.044383},{"month":7,"riseRate":0.666667,"avgChangeRate":0.074},{"month":8,"riseRate":0.666667,"avgChangeRate":0.020101},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.055485},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.035612},{"month":11,"riseRate":0.428571,"avgChangeRate":0.12272},{"month":12,"riseRate":0.666667,"avgChangeRate":0.061496}],"exchange":"NYSE","name":"Nuvation Bio, Inc.","nameEN":"Nuvation Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nuvation Bio, Inc.(NUVB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Nuvation Bio, Inc.(NUVB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Nuvation Bio, Inc.,NUVB,Nuvation Bio, Inc.股票,Nuvation Bio, Inc.股票老虎,Nuvation Bio, Inc.股票老虎国际,Nuvation Bio, Inc.行情,Nuvation Bio, Inc.股票行情,Nuvation Bio, Inc.股价,Nuvation Bio, Inc.股市,Nuvation Bio, Inc.股票价格,Nuvation Bio, Inc.股票交易,Nuvation Bio, Inc.股票购买,Nuvation Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nuvation Bio, Inc.(NUVB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Nuvation Bio, Inc.(NUVB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}